Meet The Professor: Optimizing the Management of ER-Positive and Triple-Negative Breast Cancer — Part 3

Research To Practice | Oncology Videos · Apr 27, 2023 · 1h

Featuring perspectives from Dr Sara A Hurvitz, including the following topics:

Introduction: Antibody-Drug Conjugates in Breast Cancer (0:00)

Case: A premenopausal woman in her late 40s with 0.8-cm ER/PR-positive, HER2-negative invasive ductal carcinoma (IDC) with 2 positive nodes and an Oncotype DX® Recurrence Score® (RS) of 9 — Ranju Gupta, MD (13:59)

Case: A premenopausal woman in her early 40s with 5-cm ER/PR-positive, HER2-negative Grade I IDC — Nick Leasure, MD (17:43)

Case: A woman in her early 70s with ER/PR-positive, HER2-low (IHC 1+) metastatic IDC receiving T-DXd with mixed…